We would like to take this opportunity to wish you all a Merry Christmas and a Happy New Year

During the Company implementation phase, it was decided to broaden the horizons of S&R Farmaceutici to embrace the specialisation of Urology

Just two years since its foundation S&R Farmaceutici has achieved an important milestone. Its very own ‘Revifast’ won product of the year 2017 on occasion of the European Biotechnology Congress 2017

CANDIDIASIS: FUNGAL INFECTION
THAT AFFECTS VARIOUS PARTS OF THE BODY
Candidiasis (or candidosis) is a fungal infection caused by any type of Candida yeast, a saprophyte fungus belonging to the saccharomyces family that physiologically lives in the oral cavity, gastrointestinal tract, on skin, in the vagina and in the mucosa of healthy people.

Menopause: not a disease, but a New Season! Although Menopause marks the passage from one step in life to another, in many women it triggers profound psychophysical malaise due to their irrational perception of it as a sort of danger.

The innovative results of
S&R Farmaceutici research
Barely a year on from its début on the pharmaceutical market, S&R Farmaceutici is ready to launch 2 new and highly innovative products stemming from the work of its Research and Development Division…

The role of Communication in the Pharmaceutical industry remains the main source of information on pharmaceuticals in the medical sector…

The expansion plan abroad of S&R Farmaceutici is now under way: the company is successfully concluding the first part of its foreign market penetration plan, thanks to the definition of agreements with important distributors of the sector.

The CME Course “VAGINAL INFECTIONS AND ANAEMIA IN GYNAECOLOGY AND OBSTETRICS” came to a close a few days ago and took place at the new Minerva Auditorium of S&R Farmaceutici.